Status:
COMPLETED
AED/Statin Interaction Study
Lead Sponsor:
GlaxoSmithKline
Conditions:
Epilepsy
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.
Eligibility Criteria
Inclusion
- Key
- Body weight \>50kg (men) or \>45kg (women) and BMI within the range 19-32 kg/m2 inclusive.
- No clinically significant abnormality on clinical examination
- Key
Exclusion
- History or evidence of drug or alcohol abuse or active tobacco use.
- Women of childbearing potential
- Use of prescribed or non-prescribed medications during and within 14 days of starting study medication.
Key Trial Info
Start Date :
February 4 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2008
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT00627575
Start Date
February 4 2008
End Date
September 12 2008
Last Update
August 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Buffalo, New York, United States, 14202